Article
Outcomes of Broader Genomic Profiling in Metastatic Colorectal Cancer: a Portuguese Cohort Study
2024-12-27
Abstract excerpt
<h4>Background: </h4> Colorectal cancer (CRC) is the third most diagnosed cancer globally and the second leading cause of cancer-related deaths. Despite advancements, metastatic CRC (mCRC) has a five-year survival rate below 20%. Next-generation sequencing (NGS) is recommended nowadays to guide mCRC treatment, however its clinical utility when compared with traditional molecular testing in mCRC is debated due to l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7409632-95a9-5e02-a38b-7a304138e252
- DOI
- 10.20944/preprints202412.1295.v2
